SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micromet Inc (MITI)
MITI 0.1200.0%Dec 12 11:29 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Arthur Radley9/1/2009 7:12:57 PM
  Read Replies (1) of 196
 
Next Generation Antibodies for Cancer Drugs
Event Date(s) Wednesday, September 02, 2009 to Wednesday, September 02, 2009
Event Location
Geneva, Switzerland

Description In the Life Science industry, companies across the World are looking at targets to find new innovative treatment regimes in the field of oncology. Immunotherapy is one of the most promising areas within biomedical science to successfully identify new targets for cancer treatments in the human body. Antibodies hold most promise in the treatment of cancer due to its capabilities to activate the immune system.

Today, most pharmaceutical and biotechnology companies integrate antibody therapies and technologies for new drugs in order to personalise and provide better healthcare for cancer patients. By capitalising on antibodies, biopharmaceuticals are able to provide efficient cancer therapies and diagnostics with high margins to the market worldwide.

This international one day conference will provide your R & D organisation with a platform to harness the capabilities of antibodies to develop new and innovative cancer drugs.
Sponsor n/a
Host Company n/a
Contact Information Phone: 45-3313-6250
Fax: 45-3313-6253
Email: registration@labinnovator.com
More Information
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News